Nova Pharma Solutions Bhd (XKLS:03006) Net Change in Cash : RM6.01 Mil (TTM As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Nova Pharma Solutions Bhd Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Nova Pharma Solutions Bhd's Net Change in Cash for the six months ended in Dec. 2023 was RM2.34 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 was RM6.01 Mil.

Nova Pharma Solutions Bhd Net Change in Cash Historical Data

The historical data trend for Nova Pharma Solutions Bhd's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nova Pharma Solutions Bhd Net Change in Cash Chart

Nova Pharma Solutions Bhd Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Change in Cash

Get a 7-Day Free Trial

-1.87

-1.18

1.11

0.20

6.16

Nova Pharma Solutions Bhd Semi-Annual Data
	Dec15	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Net Change in Cash	Get a 7-Day Free Trial											0.30	0.63	-0.44	3.67	2.34

Nova Pharma Solutions Bhd Net Change in Cash Calculation

Nova Pharma Solutions Bhd's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	6.605	+	0.227	+	-0.821	+	0.15
	=	6.16

Nova Pharma Solutions Bhd's Net Change in Cash for the quarter that ended in Dec. 2023

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 2.964 + 0.171 + -0.794 + 0

= 2.34

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was RM6.01 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nova Pharma Solutions Bhd Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Nova Pharma Solutions Bhd's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Nova Pharma Solutions Bhd (XKLS:03006) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Construction » Nova Pharma Solutions Bhd (XKLS:03006) » Definitions » Net Change in Cash

Comparable Companies

NSE:UNIINFO ASX:STN BOM:541006 NSE:HINDCON BOM:541083 MIL:KIP LSE:STRL TSXV:PEMC OSTO:ZUTEC XPAR:MLMIB OSL:SUNSB-ME ASX:EM2 NSE:SMSARVESHWAR HKSE:08168 HKSE:02182 HKSE:01737 HKSE:02363 LSE:SHH TSE:6570 BOM:541053

Traded in Other Exchanges

N/A

Address

Jalan USJ 25/1, Level 5, Suite C-5-1 & 2, Block C, Sky Park, One City, Subang Jaya, SGR, MYS, 47650

Website

http://www.novapharmasolutions.com

Nova Pharma Solutions Bhd provides engineering solutions to pharma and biotech industries. The company's reportable segments include Design fee, Post Design, & Other support fees. Design fee comprises conceptual designs which include user requirement specification, capacity analysis and process scheduling with detailed costing, list of deliverables, details specification of various equipment and processes. Post design fee comprise tendering and procurement support as well as the construction of a plant, & Other support fees comprise of services to assist a customer in the good manufacturing practice document review & gap analysis and assessment. It generates a majority of its revenue from the Design fee segment. Geographically, the company generates a majority of its revenue from Malaysia.

Nova Pharma Solutions Bhd (XKLS:03006) Headlines

No Headlines